Cite
HARVARD Citation
Sekizaki, T. et al. (2021). Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves' disease: A multicenter observational case–control study. Journal of diabetes investigation. 12 (11), pp. 1978-1982. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sekizaki, T. et al. (2021). Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves' disease: A multicenter observational case–control study. Journal of diabetes investigation. 12 (11), pp. 1978-1982. [Online].